ECG Belt for CRT Response
Status: | Recruiting |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 2/8/2019 |
Start Date: | July 13, 2018 |
End Date: | January 2022 |
Contact: | Peter Kratz |
Email: | peter.r.kratz@medtronic.com |
Phone: | 763-526-2802 |
The purpose of this clinical study is to compare ECG Belt Research System managed cardiac
resynchronization therapy (CRT) patients and a control CRT group with respect to left
ventricular (LV) remodeling.
resynchronization therapy (CRT) patients and a control CRT group with respect to left
ventricular (LV) remodeling.
The ECG Belt study is a prospective, interventional, randomized, multi-center,
investigational, pre-market research study. The ECG Belt Research System will be used at
implant and follow-up to help implanters choose a suitable LV pacing site within the
recommended locations for LV lead implantation and optimize pacing vector/timing parameters.
investigational, pre-market research study. The ECG Belt Research System will be used at
implant and follow-up to help implanters choose a suitable LV pacing site within the
recommended locations for LV lead implantation and optimize pacing vector/timing parameters.
Inclusion Criteria:
- Indicated for CRT, with QRS duration ≥130 ms, and planned to be implanted with a
market-released Medtronic CRT device with AdaptivCRT and a Medtronic quadripolar LV
lead.
- Meets at least one of the following criteria: QRS duration < 150 ms, Prior documented
Myocardial Infarction, Non-LBBB
- LVEDD ≥ 55 mm, as determined by site
Exclusion Criteria:
- Permanent/persistent AF or presenting with AF
- Pre-existing or previous LV lead or other confounding devices e.g. Left Ventricular
Assist Device, Vagal Nerve Stimulator
- Currently implanted with IPG or ICD with > 10% RV pacing
- Permanent complete AV block
- Enrolled in a concurrent study that may confound the results of this study.
Pre-approval from the study manager is required for enrollment of a patient that is in
a concurrent study.
- Less than 1 year life expectancy
- Vulnerable adults
- Younger than 18 years of age
We found this trial at
11
sites
3400 Spruce St
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
(215) 662-4000
Principal Investigator: David Frankel, Dr.
Hospital of the University of Pennsylvania The Hospital of the University of Pennsylvania (HUP) is...
Click here to add this to my saved trials
9500 Euclid Avenue
Cleveland, Ohio 44106
Cleveland, Ohio 44106
216.444.2200
Principal Investigator: Niraj Varma, Dr.
Cleveland Clinic Cleveland Clinic is committed to principles as presented in the United Nations Global...
Click here to add this to my saved trials
Austin, Texas 78758
Principal Investigator: Robert Canby, Dr.
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
2301 Erwin Rd
Durham, North Carolina 27710
Durham, North Carolina 27710
919-684-8111
Principal Investigator: Kevin Jackson, Dr.
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Gainesville, Florida
Principal Investigator: Thomas Burkart, Dr.
Click here to add this to my saved trials
4401 Wornall Rd
Kansas City, Missouri 64111
Kansas City, Missouri 64111
(816) 932-2000
Principal Investigator: Brian Ramza, Dr.
Saint Luke's Hospital, Kansas City Saint Luke's Hospital is a not-for-profit tertiary referral center committed...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials